LianBio

LianBio is a cross-border biotechnology company with the mission of bringing transformative medicines to underserved patients in China and other Asian markets. By collaborating with highly innovative biopharmaceutical companies worldwide, LianBio is advancing a diversified portfolio of clinically validated product candidates that have the potential to establish new standards of care across cardiovascular, oncology, ophthalmology, inflammatory diseases, and respiratory indications. We focus on identifying the best opportunities to create new therapeutic paradigms for first-in-class programs. Guided by science-driven insights, we select products and unique technology platforms based on proven scientific capabilities, aiming to make a broad impact on unmet medical needs.